This invention relates to a system and process for determining composition and components of fluids. More specifically the present invention provides improved techniques for viewing cellular morphology, and determining the number of a particular type of cell in a portion of a body fluid.
Pathology is a field of medicine where medical professionals determine the presence, or absence of disease by methods that include the morphologic examination of individual cells that have been collected, fixed or air-dried, and then visualized by a stain that highlights features of both the nucleus and the cytoplasm. The collection of the cells often involves capturing a portion of a person's body fluid, placing the body fluid on a slide, and viewing the fluid on the slide using a microscope.
One of the most commonly performed pathologic studies is the CBC (the Complete Blood Count). To perform a CBC, a sample of blood is extracted from a patient and then the cells are counted by automated or manual methods. The CBC is commonly performed by using an instrument, based on the principal of flow cytometry, which customarily aspirates anticoagulated whole blood and divides it into several analysis streams. Using the flow cytometer a number of primary and derived measurements can be determined including: i) red blood cell (RBC) count, hemoglobin (Hb), hematocrit (Hct), red blood cell indices (mean corpuscular volume, MCV, mean corpuscular hemoglobin, MCH and mean corpuscular hemoglobin concentration MCHC), red blood cell distribution width, enumeration of other red blood cells including reticulocytes and nucleated red blood cells, and red blood cell morphology; ii) white blood cell (WBC) count and WBC “differential” count (enumeration of the different normal white blood cell types, including neutrophils, lymphocytes, eosinophils, basophils and monocytes, and the probable presence of other normal and abnormal types of WBC that are present in various disease conditions); and iii) platelet count, platelet distribution widths and other features of platelets including morphological features. In flow cytometers, red blood cell, WBC, and platelet morphological characterizations are typically made indirectly, based on light absorption and light scattering techniques and/or cytochemically based measurements. Some advanced flow cytometers calculate secondary and tertiary measurements from the primary measurements.
Flow based CBC instruments generally require extensive calibration and control, maintenance, and skilled operators, and they have substantial costs associated with acquisition, service, reagents, consumables and disposables. One significant problem with these systems in routine use is that a large proportion of blood specimens require further testing to complete the assessment of the morphologic components of the CBC. This involves placing a sample of blood on a slide, smearing the sample against the slide to form a wedge smear, and placing the slide under a microscope. This process is often done manually by skilled medical technologists, which increases the cost and time to receive results from the tests. The direct visualization of blood cells on a glass slide must be performed whenever the results of the automated test require further examination of the blood sample. For example, a “manual” differential count is performed by direct visualization of the cells by an experienced observer whenever nucleated immature RBCs are found or WBCs suspicious for infection, leukemias or other hematologic diseases are found.
The proportion of these specimens requiring further review generally ranges from 10% to 50%, depending on the laboratory policy, patient population and “flagging” criteria, with a median rate of around 27%. The most frequent reasons for retesting include the presence of increased or decreased number of WBCs, RBCs or platelets, abnormal cell types or cell morphology, clinical or other suspicion of viral or bacterial infections.
In addition to additional work involved in performing manual differential counts, this process has a number of additional technical limitations. These include distortions of cell morphology because of mechanical forces involved in smearing the cells onto the slide, and cells overlapping one another, which makes visualization of individual cell morphology difficult.
The present invention provides systems and methods for placing cells on a slide. Additionally systems and method for imaging the cells are provided. The images may be later used to perform tests such as a complete blood count including image-based counting and assessment of the morphology of the formed elements of blood, including RBCs, WBCs, and platelets. Embodiments of the present invention may improve the accuracy of the CBC by providing improved visualization of the formed elements of blood. Aspects of the present invention may analyze and determine the presence of certain cell types, such as abnormal or immature WBCs that are found in cases of abnormal bone marrow function including hematological malignancies. Further, the configurations of the present invention may decrease costs associated with instrumentation, decrease costs of consumables and reagents, require less operator time and reagents, fewer repeated tests, and fewer moving parts than other prior art techniques. Configurations of the present invention may also reduce the turn around time for many of the CBC tests that currently require visualization of blood cells after the instrumental portion of the test is completed, by allowing cells to be visualized on a monitor instead of under a microscope.
Aspects of the present invention are effective at preserving cell morphology. This may be important for patients with hematological malignancies such as chronic lymphocytic leukemia (CLL) or acute myeloid leukemia (AML). The systems and methods relating to applying a monolayer of cells to a slide may enable detection of a larger number of morphologically well-preserved blast cells and other immature or fragile cells. This would allow their more accurate recognition at an earlier stage of the leukemic or other disease process. Certain aspects of the present invention provide for preparing a substantially uniform distribution of cells across a test area of a slide.
Aspects of the present invention also relate to collecting cells in a fluid (such as blood) from organic tissue, possibly mixing the cells contained in the fluid with a diluent, collecting a sub-sample (aliquot) of a known volume from the solution, and then depositing the aliquot onto a substratum such as a slide using a dispensing device or applicator. The cells may be allowed to air dry or may be fixed (using a fixative solution) or both, depending on the examination that is anticipated. The cells may also be stained. The stained cells on the substratum may be counted and examined by an automated imaging system utilizing a computer or viewed by manual microscopic examination. Digital images may be shown on a computer display to reduce the need for manual microscopic review.
With reference to
In embodiments which feature a platform 100, an advancer 110 may be configured to receive one or more slide apparatuses 700-700″. The advancer 110 may be attached to a surface, such as the top surface 101, of the platform. The advancer 110 may take the form of a belt as shown in
The platform 100 may also comprise a feeder 102 and a collector 106 for respectively feeding and collecting the slide apparatuses 700 from or to a stack or rack. The feeder 102 may be equipped with a feeder propulsion mechanism 103 (such as rubberized wheels) for pushing the slides down a ramp 104 onto the advancer 110. (Of course embodiments of the invention could be built without a ramp. For example, if the feeder is level with advancer 110, no ramp would be needed. Alternatively, a mechanical arm could be used to grab the slide apparatus 700 and place the slide apparatus 700 on the advancer directly.) Alternate mechanisms to propel the slide out of the feeder 102 may be used such as magnets or hydraulics. The feeder may comprise a sensor for determining how many slides are present. The sensor could measure the weight of the slide apparatuses 700 for example to determine how many slide apparatuses were present.
The light receiving device 200 may be a microscope (such as brightfield microscope), a video camera, a still camera, or other optical device which receives light. In embodiments using a standard brightfield microscope, one containing an automated stage (a slide mover 201) and focus may be selected. In one embodiment, a microscope may be attached to a motorized stage and a focus motor attachment. The microscope may have a motorized nosepiece, for allowing different magnification lenses to be selected under computer 300 control. A filter wheel may allow the computer 300 to automatically select narrow band color filters in the light path. LED illumination may be substituted for the filters, and use of LEDs may reduce the image acquisition time as compared to the time required for filter wheel rotation. A 1600×1200 pixel firewire camera may be used to acquire the narrow band images.
In some cases, the light receiving device will receive light reflected off slide apparatus 700″ and store an image of that light. In some embodiments fluorescent emission from the cellular objects may be detected in the light receiving device 200. However, since the light emission source 600 can be positioned below the platform, the light emission source may direct light so that it passes through the platform 100 and the slide 701 into the light receiving device 200. The light receiving device may be connected to a computer through a link 11, and may be capable of X, Y, and Z axial movement (in other embodiments a motorized stage or slide mover 201 may provide X, Y, and Z movement.) The light receiving device may comprise a link 11 such as a wire as shown in
The computer 300 may be a laptop as shown in
Although shown as one component, computer 300 may comprise multiple computers and a first computer could be used for controlling the components and a second computer could be used for processing the images from the light receiving device 200. In some embodiments, the various computer may be linked together to allow the computer to share information. The computer 300 may also be connected to a network or laboratory information system to allow the computer to send and receive information to other computers.
The applicator station includes 1) a precision automated dispenser tip that allows very small volumes of fluids to be handled and 2) automated movement of a substrate under the tip to allow the volume of fluid, e.g., diluted blood, to be dispensed over a defined area of the substrate.
In certain embodiments, the applicator 400 may comprise a syringe, a manual or motor driven pipettor or using a motor controlled pump attached through a tube to a pipette tip. While many different types of pipettes or syringes could be used, test results have shown improved results can be obtained through using an applicator 400 having better than 2% accuracy. The pump may be a peristaltic pump, a syringe pump, or other similar device that allows small volumes to be aspirated and dispensed through an orifice. Typically such an orifice will be contained in a tip 405 that is two to five millimeters in outside diameter with an inner diameter of 0.5 millimeters. The tip 405 may be disposable or washable. The tip 405 may be rounded to facilitate insertion and cleaning of the tip. Fluid flow through the tip is controlled to allow a thin layer of blood or diluted blood to be deposited onto the slide. By optimizing flow rate through the tip and the relative speed and height of the tip over the slide an appropriate density of cells can be deposited onto the slide. Each of these factors influences the other, so the proper combination of height, flow rate through the tip, and speed over the slide must be determined. In one embodiment the flow rate through the tip is 0.1 microliters per second while the tip is moving at a speed of 30 millimeters per second over the slide surface at a height of about 70 microns.
In use, the applicator 400 may comprise a known volume of body fluid such as 30 microliters (ul). The applicator may mix this fluid with a stain or diluent, and eject a portion of this fluid onto the slide apparatus 700 (particularly the specimen zone 710,
The system 10 or applicator 400 may contain one or more dispensers 800. The dispenser 800 (or 450 in
In the embodiment shown in
Various fixatives and diluents may be used with the present invention. For example 85% methanol can be used as the fixative. For some stains an ethyl alcohol or formaldehyde based fixative might be used. Diluents useful for diluting whole blood for example, may include salt solutions or protein solutions. Salt solutions range from “physiological saline” (0.9N), to complex mixtures of salts, to the commercial preparation PLASMALYTE® that simulates virtually all the salts found in human blood serum. Protein solutions can range from simple solutions of bovine albumin to PLASMANATE®, a commercial preparation with selected human plasma proteins. Such preparations can vary in protein concentrations, buffers, pH, osmolarity, osmalality, buffering capacity, and additives of various types. Synthetic or “substitute” versions of these solutions may also be usable, including FICOLL® or Dextran or other polysaccharides. Other substitutes may be used. An example of a diluent is PLASMALYTE® plus PLASMANATE® in the proportion of 4:1 (PLASMALYTE®:PLASMANATE®). Another example of a diluent is 5% albumin. When analyzing whole blood, a dilution of 2 parts blood to 1 part diluent can be used, where the diluent is a physiologically compatible solution, but a range of dilution from 0:1 (no dilution) to 10:1 (diluent:blood) may be used in alternate embodiments.
The applicator may comprise a hydraulic piston for pushing the fluid out of fluid chamber 410 (like a syringe or a pipette). A tip 405 may be provided for adjusting the flow rate of the fluid. While size of the tip does not affect the speed (μl/sec) in which the solution flows out of the tip, generally, the smaller the opening in the tip, the greater the force (μg*distance/seconds2). Additionally, the size of the tip affects thickness of the fluid flows 750 shown in
To physically place the cells on the slide 701, the computer 300 could direct the applicator controller 490 to perform the body fluid application process 7B (see
The computer 300 may be connected to the applicator controller 490 to control this movement. In the embodiment shown in
The number of cells placed on the slide 701 using this method will vary depending on the type of fluid being examined and the dilution ratio. Assuming whole blood were being analyzed with a 1:3 (blood:diluent ratio), about 900,000 red blood cells, 45,000 platelets, and 1,000 white blood cells would be placed on the slide. Though
Gas movement device 500 may comprise a fan (such as shown in
Two different embodiments of light emission device 600 are illustrated. In
Various wavelengths of light may be directed by the light emission device 600. Two-eight or more different wavelengths of light may be directed at the slide apparatus 700. Wavelengths such as 430 nm are useful for imaging a hemoglobin-only image for assessing RBC morphology and hemoglobin content. Using an image taken with such a wavelength which is designed to show only red blood cells, it may also show red blood cells which are touching white blood cells. The touching red blood cells may be digitally removed from images to make it easier for the computer to detect the white blood cell borders in order to make more accurate cellular measurements and enumeration. Light emitted at 570 nm may be useful to provide high contrast images for platelets and nuclei. Other wavelengths may be chosen in order to best discriminate the colors of basophils, monocytes, lymphocytes (all shades of blue), eosinophils (red), and neutrophils (neutral color). For counting platelets, for example, two colors of illumination may be used (such as 430 nm and 570 nm). A high contrast image may be obtained by subtracting the 430 nm image from the 570 nm image. Light having a wavelength of 430, 500, 525 and 600 are particularly effective at showing cell color information, but light at wavelengths between 400 nm and 700 nm inclusive may be used. These wavelengths will also be used for the display of the color images if appropriate. Otherwise one or two additional images may need to be taken for the 200+ cells that will be analyzed for the differential count and which may be shown on the display 320. Typically the narrow-band images will be chosen from the range of 400 nm to 750 nm. Test results have shown that 2-8 separate light colors to work well, with 3-4 separate light colors being optimal. The computer 300 may be able to further refine the images by compensating for spatial shifts. Also the computer may combine the various colored images to generate multi color images for display or analysis. Numeric descriptors of the individual images or combined images can be used to determine spatial, densitometric, colorimetric and texture features of the cells for classification of the cell types. A further advantage of using narrow band illumination is that using narrow band illumination allows for the elimination of the use of oil objectives or coverslips. Light is refracted when the light passes from glass to air. Prior art systems have used oil objectives or coverslips to minimize this refraction at air to glass transitions, but having to add oil or coverslips adds steps to processing the slides, and increases the per slide analysis cost. To overcome, the need to use coverslips or oil, a combination of narrow band LEDS or filtered light can be used. Reducing the variance or bandwidth in the wavelengths of the light decreases the distortion in the image captured by the light receiving device 200 when the light passes through the slide 701. The computer 300 may also instruct the light emission device 600, to focus the light from the light source (either 610 or 630) so that the light is properly focuses on the slide. To do this, the computer 300 may instruct a focus adjustor to optimize the focus for each color of light.
With reference to
The system 10 may optionally include a slide labeler 1000 and optionally a slide label reader 1100. The slide label reader 1000 may situated on the platform 100 near the feeder 102 as shown in
The system 10 may comprise a slide label reader 1100. Slide label reader 1100 may read markings placed on the slide from the slide labeler 1000 or by labelers external to the system. The slide label reader 1100 could comprise an interrogator, a bar code reader, or other optical device. In some embodiments, the system 10 may be able to determine information from the labels 770 without a slide label reader 1100 by using the light receiving device 200 to capture an image of the label 770. The computer 300 or the light receiving device (if it contains a processor and memory) could perform imaging processing on the image containing the label and determine the information about the label 770.
As discussed above, the present invention may be used to analyze peripheral or whole blood. The invention can also be used, however, to study cells of various types of body fluids. For example, the preparation methods and analysis techniques described here can also be applied to bone marrow aspiration samples. Bone marrow samples have a higher cellular density and contain many immature red and white blood cell types that are seldom found in peripheral blood. The technique of preparing a thin layer of cells, staining with a Romanowsky stain and analyzing with image analysis can be applied to bone marrow aspirates as well, however more sophisticated image analysis may be needed to discriminate the additional types of cells.
As with peripheral blood samples, bone marrow samples may be collected into a container with an anticoagulant. This anticoagulant may be EDTA or heparin. Additional diluting or preserving fluid may be added to the sample. In the instrument described here a bone marrow sample would be prepared by first agitating the sample to provide a thorough mixing. Due to the uncertain cellular density of such samples one or more dilutions may be prepared and pipetted onto the slide or slides. In one embodiment, a triple dilution process may be used to create three specimens. A first specimen may be created by adding 2 parts diluent to one part bone marrow. The first specimen may then be ejected onto a first portion of the specimen zone 710 of the slide 701. A second specimen may be created by adding four parts diluent to the bone marrow. The second specimen may then be ejected onto a second portion of the specimen zone 710 of the slide 701. A third specimen may be created by adding eight parts of diluent to the marrow. The third may then be ejected onto a third portion of the specimen zone 710 of the slide 701.
For the image analysis, a low magnification assessment of the cellular area on the slide could choose the optimum one third for subsequent analysis. Once the proper area of the slide is selected, 200+ bone marrow cells would be measured to determine the differential count.
The system 10 may also count the number of reticulocytes in a blood sample. Using a Romanowsky stain to mark RNA, the computer 300 can count the number of reticulocytes present in the specimen. When a Romanowsky stain is used, the reticulocytes appear slightly bluer than other red blood cells, and are usually slightly larger. The computer 300 can use its analysis process (16A or 17B, of
Embodiments of the present invention are contemplated to process multiple slide apparatuses 700 in a pipelined series as shown in
In the embodiment shown in
A second process flow is shown in
To determine the accuracy of this method, computer algorithms were developed to count RBCs and WBCs from digital images.
The image shown in
An accurate count may be made by scanning the entire preparation for red blood cells and white blood cells, but an accurate platelet count might use a reduced number of fields, since an average cell deposition will have a total of around 30,000 platelets, or approximately 500 platelets per field. The image analysis programs then analyze each individual field and sum the total red and white cell counts. To calculate the total counts per microliter in the patient vial, the number counted on the slide is multiplied by the dilution factor.
Table 1 below shows a summary of data for 34 slides. “Invention” data represents red and white blood cell counts from slides produced using the method described above, and analyzed using image analysis counting algorithms. “Sysmex” data represents red and white blood cell counts from a commercial “flow-based” automated CBC analyzer. Note that the specimens include very high and very low red blood cell counts and white blood cell counts.
The data was obtained from 34 patient samples during two sessions of preparing slides. The data is representative of typical patients, although the tubes were selected from patients with a wide distribution of red and white cell counts. Most, if not all of the 34 samples, were obtained from specimens “archived” during the day in the refrigerator, and then pulled and prepared on the instrument in the late afternoon. Once the tubes were pulled, they were processed consecutively.
The algorithms were first validated by comparing manually counted microscope fields to the automated counts. There is a high correlation between the manually counted cells and the automatically counted cells.
High correlation between the two methods was found for both the red blood cell counts and the white blood cells counts (see Tables 1 and 2 and
The following sequence of steps may be performed in any order and some steps may be omitted or replaced with other steps.
This application is a continuation application of U.S. application Ser. No. 12/430,885, filed on Apr. 27, 2009 (now U.S. Pat. No. 9,017,610), which claims priority under 35 U.S.C. § 119 to U.S. Provisional Application No. 61/047,920, filed on Apr. 25, 2008. Further, the present application expressly incorporates herein by reference the application entitled “SYSTEMS AND METHODS FOR ANALYZING BODY FLUIDS,” U.S. Provisional Application No. 61/173,186, which was filed on Apr. 27, 2009 by the same inventors as the present application. The contents of each of these applications are expressly incorporated herein by reference in their entirety.
This invention was made with Government support under NIH Grant Number HL077033. The Government has certain rights in this invention.
Number | Name | Date | Kind |
---|---|---|---|
3503684 | Preston, Jr. et al. | Mar 1970 | A |
3572890 | Adamik | Mar 1971 | A |
3888206 | Faulkner | Jun 1975 | A |
3960488 | Giaever | Jun 1976 | A |
3985096 | Guimbretiere | Oct 1976 | A |
4094196 | Friswell | Jun 1978 | A |
4175859 | Hashizume et al. | Nov 1979 | A |
4207554 | Resnick et al. | Jun 1980 | A |
4285907 | Hugemann et al. | Aug 1981 | A |
4362386 | Matsushita et al. | Dec 1982 | A |
4395493 | Zahniser et al. | Jul 1983 | A |
4465212 | Boone | Aug 1984 | A |
4468410 | Zeya | Aug 1984 | A |
4478095 | Bradley et al. | Oct 1984 | A |
5123055 | Kasdan | Jun 1992 | A |
5209903 | Kanamori et al. | May 1993 | A |
5338688 | Deeg et al. | Aug 1994 | A |
5419279 | Carrico, Jr. et al. | May 1995 | A |
5436978 | Kasdan | Jul 1995 | A |
5625705 | Recht | Apr 1997 | A |
5650332 | Gao et al. | Jul 1997 | A |
5658802 | Hayes et al. | Aug 1997 | A |
5665309 | Champseix | Sep 1997 | A |
5665312 | Sperber et al. | Sep 1997 | A |
5676910 | Levine et al. | Oct 1997 | A |
5738728 | Tisone | Apr 1998 | A |
5741554 | Tisone | Apr 1998 | A |
5743960 | Tisone | Apr 1998 | A |
5766549 | Gao et al. | Jun 1998 | A |
5804145 | Gao et al. | Sep 1998 | A |
5807522 | Brown et al. | Sep 1998 | A |
5882933 | Li et al. | Mar 1999 | A |
6110425 | Gao et al. | Aug 2000 | A |
6132353 | Winkelman et al. | Oct 2000 | A |
6150173 | Schubert | Nov 2000 | A |
6151405 | Douglass et al. | Nov 2000 | A |
6228652 | Rodriguez et al. | May 2001 | B1 |
6249344 | Virag | Jun 2001 | B1 |
6258322 | Meikle | Jul 2001 | B1 |
6268611 | Pettersson et al. | Jul 2001 | B1 |
6269846 | Overbeck et al. | Aug 2001 | B1 |
6287791 | Terstappen et al. | Sep 2001 | B1 |
6319470 | Lefevre et al. | Nov 2001 | B1 |
6350613 | Wardlaw et al. | Feb 2002 | B1 |
6398705 | Grumberg et al. | Jun 2002 | B1 |
6489625 | Takahashi et al. | Dec 2002 | B1 |
6519355 | Nelson | Feb 2003 | B2 |
6553135 | Douglass | Apr 2003 | B1 |
6576295 | Tisone | Jun 2003 | B2 |
6590612 | Rosenqvist | Jul 2003 | B1 |
6711283 | Soenksen | Mar 2004 | B1 |
6718053 | Ellis | Apr 2004 | B1 |
6866823 | Wardlaw | Mar 2005 | B2 |
6869570 | Wardlaw | Mar 2005 | B2 |
6902703 | Marquiss | Jun 2005 | B2 |
7006674 | Zahniser et al. | Feb 2006 | B1 |
7025933 | Ganz et al. | Apr 2006 | B2 |
7105081 | Gascoyne et al. | Sep 2006 | B2 |
7105295 | Bass et al. | Sep 2006 | B2 |
7109477 | Kuzan et al. | Sep 2006 | B2 |
7190818 | Ellis | Mar 2007 | B2 |
7297311 | Tamura et al. | Nov 2007 | B2 |
7300804 | Sellek-Prince | Nov 2007 | B2 |
7327901 | Karlsson et al. | Feb 2008 | B2 |
7368080 | Tamura et al. | May 2008 | B2 |
7561329 | Zahniser et al. | Jul 2009 | B2 |
7587078 | Zahniser et al. | Sep 2009 | B2 |
7597845 | Domack | Oct 2009 | B2 |
7608220 | Jin et al. | Oct 2009 | B2 |
7689038 | Zahniser | Mar 2010 | B2 |
7716303 | Moricz | May 2010 | B2 |
7767147 | Adachi et al. | Aug 2010 | B2 |
7790107 | Nakaya | Sep 2010 | B2 |
7796797 | Nakaya et al. | Sep 2010 | B2 |
7820381 | Lemme et al. | Oct 2010 | B2 |
7833485 | Higuchi et al. | Nov 2010 | B2 |
7881532 | Zahniser | Feb 2011 | B2 |
7903241 | Wardlaw | Mar 2011 | B2 |
7929122 | Wardlaw | Apr 2011 | B2 |
8058010 | Erickson | Nov 2011 | B2 |
8067245 | Van Ryper et al. | Nov 2011 | B2 |
8081303 | Levine | Dec 2011 | B2 |
8263414 | Pugia | Sep 2012 | B2 |
8284384 | Levine | Oct 2012 | B2 |
8361799 | Levine | Jan 2013 | B2 |
20020049391 | Kuracina | Apr 2002 | A1 |
20020085744 | Domanik et al. | Jul 2002 | A1 |
20020086431 | Markham et al. | Jul 2002 | A1 |
20020159919 | Churchhill | Oct 2002 | A1 |
20020182623 | Lefevre et al. | Dec 2002 | A1 |
20030030783 | Roche et al. | Feb 2003 | A1 |
20040131758 | Jung et al. | Jul 2004 | A1 |
20050003464 | Tibbe et al. | Jan 2005 | A1 |
20050025672 | Nakaya et al. | Feb 2005 | A1 |
20050058330 | Mitsuhashi et al. | Mar 2005 | A1 |
20050074361 | Tanoshima et al. | Apr 2005 | A1 |
20050212837 | Nakagawa et al. | Sep 2005 | A1 |
20060051241 | Higuchi et al. | Mar 2006 | A1 |
20060144331 | Hanafusa et al. | Jul 2006 | A1 |
20060263902 | Pugia | Nov 2006 | A1 |
20070076983 | Doerrer | Apr 2007 | A1 |
20070128073 | Tappen | Jun 2007 | A1 |
20070148046 | Nakaya | Jun 2007 | A1 |
20080020128 | Van Ryper et al. | Jan 2008 | A1 |
20080210894 | Ahn et al. | Sep 2008 | A1 |
20080318305 | Angros | Dec 2008 | A1 |
20090032583 | Lapstun et al. | Feb 2009 | A1 |
20090069639 | Linssen et al. | Mar 2009 | A1 |
20090155841 | Yamasaki | Jun 2009 | A1 |
20090162862 | Merz | Jun 2009 | A1 |
20090176316 | Giter et al. | Jul 2009 | A1 |
20090191585 | Yamada et al. | Jul 2009 | A1 |
20090233331 | Ostgaard et al. | Sep 2009 | A1 |
20090239257 | Levine | Sep 2009 | A1 |
20090269799 | Winkelman et al. | Oct 2009 | A1 |
20090275076 | Knesel et al. | Nov 2009 | A1 |
20100027868 | Kosaka et al. | Feb 2010 | A1 |
20100054575 | Zhou et al. | Mar 2010 | A1 |
20100111399 | Ramirez et al. | May 2010 | A1 |
20100284602 | Winkelman et al. | Nov 2010 | A1 |
20110014645 | Winkelman | Jan 2011 | A1 |
20120147357 | Wardlaw | Jun 2012 | A1 |
20130070077 | Winkelman | Mar 2013 | A1 |
Number | Date | Country |
---|---|---|
1385701 | Dec 2002 | CN |
1793919 | Jun 2006 | CN |
1945326 | Apr 2007 | CN |
3 503 475 | Aug 1985 | DE |
0 810 428 | Dec 1997 | EP |
0 861 431 | Mar 2000 | EP |
1 387 171 | Feb 2004 | EP |
1 804 046 | Jul 2007 | EP |
1 812 799 | Aug 2007 | EP |
1 957 205 | Aug 2008 | EP |
2 072 993 | Jun 2009 | EP |
2 083 375 | Jul 2009 | EP |
2 202 523 | Jun 2010 | EP |
1349379 | Apr 1974 | GB |
60-162955 | Aug 1985 | JP |
H2-52254 | Feb 1990 | JP |
H4-104036 | Apr 1992 | JP |
07-020650 | Jan 1995 | JP |
7-83817 | Mar 1995 | JP |
2008-507806 | Aug 1996 | JP |
2009-033411 | Feb 1997 | JP |
11-326208 | Nov 1999 | JP |
2005-00573 | Jan 2000 | JP |
2000199763 | Jul 2000 | JP |
2001-17 4456 | Jun 2001 | JP |
2001-518186 | Oct 2001 | JP |
2002-516982 | Jun 2002 | JP |
2005-000573 | Jan 2005 | JP |
5518184 | Oct 2012 | JP |
WO 9420856 | Sep 1994 | WO |
WO 97018457 | May 1997 | WO |
WO 9726541 | Jul 1997 | WO |
WO 9944593 | Sep 1999 | WO |
WO 9963324 | Dec 1999 | WO |
WO 0104276 | Jan 2001 | WO |
WO 01061361 | Aug 2001 | WO |
WO 2005022125 | Mar 2005 | WO |
WO 2005080940 | Sep 2005 | WO |
WO 2006024716 | Mar 2006 | WO |
WO 2007067847 | Jun 2006 | WO |
WO 2006127631 | Nov 2006 | WO |
WO 2007105198 | Sep 2007 | WO |
WO 2008046292 | Apr 2008 | WO |
WO2008140969 | Nov 2008 | WO |
WO 2009033128 | Mar 2009 | WO |
WO 2010053869 | May 2010 | WO |
Entry |
---|
Aller, R., et al., “High Volume Hematology Analyzers: Getting Better All the Time”, CAP Today, pp. 27-34 (Dec. 2000). |
Aus, H. M., et al., “Bone Marrow Cell Scene Segmentation by Computer-Aided Color Cytophotometry,” The Journal of Histochemistry and Cytochemistry, vol. 25, No. 7, pp. 662-667 (1977). |
Bacus, “Image Processing for Automated Erythrocyte Classification” The Journal of Histochemistry and Cytochemistry 24: 195-201 (1976). |
Bacus, “An Automated Method of Differential Red Blood Cell Classification with Application to the Diagnosis of Anemia” The Journal of Histochemistry and Cytochemistry 25:614-632 (1977). |
Bacus, “Quantitative Red Cell Morphology,” Monogr. Clin. Cytol. 9: 1-27 (1984). |
Bacus, J., “Erythrocyte Morphology and Centrifugal ‘Spinner’ Blood Film Preparations”, The Journal of Histochemistry and Cytochemistry, vol. 22:506-516 (1974). |
Bacus, J.W., “Cytometric approaches to red blood cells”, Pure & Appl. Chem., vol. 57:593-598 (1985). |
Bacus, J.W., “Digital Image Processing Measurements of Red Blood Cell Size and Hemoglobin Content”, Advances in Hematological Methods: The Blood Count, Chapter 14, 158-181 (1982). |
Bacus, J.W., “Quantitative Morphological Analysis of Red Blood Cells”, Blood Cells, vol. 6:295-314 (1980). |
Brenner, J.F., et al., “Automated Classification of Normal and Abnormal Leukocytes”, The Journal of Histochemistry and Cytochemistry, vol. 22:697-706 (1974). |
Brenner, John F., et al., “An Automated Microscope for Cytologic Research a Preliminary Evaluation,” The Journal of Histochemistry and Cytochemistry, vol. 24, No. 1, pp. 100-111 (1976). |
Cornet et al., “Performance evaluation and relevance of the cellavision DM96 system in routine analysis and in patients with malignant hematological diseases,” International Journal of Laboratory Hematology, vol. 30 pp. 536-542 (2007). |
Daoust, P.R., “The Clinical Detectionof Variations in the Concentrations of Noral Leukocyte Types: A Laboratory Comparison of 100-Cell Manual Differential Counts on Wedge Smears and 500-Cell Counts by the ADC500”, Blood Cells, vol. 6:489-496 (1980). |
De Cresce et al., “PAPNETIM Cytological Screening System,” Laboratory Medicine 22(4):276-280, Apr. 1991. |
Dunlop, M. Joan, et al., “Kinetics of Adhesive Interaction In-Vitro of Human Erythrocytes in Plasma,” Microvascular Research, 28(1): 62-74 (1984). |
Gelemsa et al., “Procedures for the automation of the white blood cell differential count; NTG/GI Gesellschaft fur Informatik Nachwichtentechnische Gesellschaft Fachtagung Cognitive Verfahren und Systeme”, Springer-Verlag, Berlin pp. 237-256 (1973). |
Green, James E., “A Practical Application of Computer Pattern Recognition Research The Abbott ADC-500 Differential Classifier,” The Journal of Histochemistry and Cytochemistry, vol. 27, No. 1, pp. 160-173 (1979). |
Gulati et al., “Criteria for blood smear review,” Laboratory Medicine, vol. 33, No. 5 pp. 374-377 (2002). |
Kingsley, T.C., “The Automated Differential; Pattern Recognition Systems, Precision, and the Spun Smear”, Blood Cells, vol. 6:483-487 (1980). |
Lehman, C., et al., “Image Technology and its Role in Hematology”, Advance/Laboratory, pp. 84-88 (May 2000). |
Meyer, E., “Vickers Continuous Film”, Cytology Automation: Proceedings of Second Tenovus Symposium, Cardiff 24th-25th, nn.147-53 (Oct. 1968). |
Miller, M.N., “Design and Clinical Results of Hematrak®: An Automated Differential Counter”, IEEE Transactions on Biomedical Engineering, vol. BME-23:400-405 (1976). |
Novis, D., et al., “Laboratory Productivity and the Rate of Manual Peripheral Blood Smear Review: A College of American Pathologists Q-Probes Study of 95141 Complete Blood Count Determinations Performed in 263 Institutions”, Archives of Pathology and Laboratory Medicine, vol. 130:596-601 (2006). |
Rogers, C., “Blood Sample Preparation for Automated Differential Systems”, American Journal of Medical Technolof!V, vol. 39: 435-442 (1973). |
Seiter, C., et al., “Contact Angles: New Methods and Measurements”, American Laboratory, p. 26 (Feb. 2002). |
Smit, J.W., et al., “A commercially available interactive pattern recognition system for the characterization of blood cells: description of the system, extraction and evaluation of simple geometrical parameters of normal white cells”, Clin. Lab. Haemat. vol. 1:109-119 (1979). |
Walker, T., “Comparative Evaluation of the Iris iQ200 Body Fluid Module with Manual Hemacytometer Count”, American Journal of Clinical Patholof;)1, vol. 131:333-338 (2009). |
Walters, J., et al., “Performance Evaluation of the Sysmex XE-2100 Hematology Analyzer”, Laborator y Hematolo5′Y , vol. 6:83-92 (2000). |
Ward, P., “The CBC at the Turn of the Millenium: An Overview”, Clinical Chemistry, vol. 46:1215-1220 (2000). |
Zahniser, DJ., et al., “Detecting Infection-Related Changes in Peripheral Blood Smears with Image Analysis Techniques”, Reprinted from Analytical and Quantitative Cytologv, vol. 5:269-274 (1983). |
Zahniser, DJ., et al., “Spectral Bandwidth in Automated Leukocyte Classification”, Cytometry, vol. 7:518-521 (1986). |
Paredes Sanchez, Luis-Miguel, “Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration”, International Aoolication No. PCT/US2009/041858, dated Aug. 10, 2010 (14 pages). |
Salaun, Marion, “Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration”, Internatinal Application No. PCT/US201 1/021546, dated Jan. 18, 2011 (14 oages). |
Bai, Lingfei, “Notification Concerning Transmittal of International Preliminary Report on Patentability”, International Application No. PCT/US2010/032612, dated Nov. 1, 2011 (2 pages). |
Young, Lee W., “Written Opinion of the International Searching Authority”, International Application No. PCT/US2010/032612, dated Jun. 28, 2010 (11 pages). |
English translation of the Written Opinion of the International Searching Authority for PCT/CN2007/002665 dated Nov. 15, 2007, 5 pages. |
International Preliminary Report on Patentability for PCT/US2009/041858, dated Feb. 28, 2012, 6 pages. |
International Preliminary Report on Patentability for PCT/US2011/021546 dated Aug. 1, 2013, 7 pages. |
International Search Report and Written Opinion for PCT/US2009/041858, dated Jun. 28, 2010, 13 pages. |
Office Action in U.S. Appl. No. 12/768,633 dated Jun. 26, 2013, 15 pages. |
Office Action in U.S. Appl. No. 12/768,633, dated Oct. 18, 2012, 21 pages. |
Office Action in U.S. Appl. No. 12/785,314 dated Apr. 30, 2013, 18 pages. |
Office Action in U.S. Appl. No. 12/785,314 dated Nov. 26, 2013, 41 pages. |
Office Action in U.S. Appl. No. 12/785,314, dated Oct. 12, 2012, 30 pages. |
Office Action in U.S. Appl. No. 12/785,337 dated Nov. 21, 2013, 24 pages. |
Office Action in U.S. Appl. No. 13/619,381, dated Jan 15, 2014, 7 pages. |
Office Action in U.S. Appl. No. 13/619,381, dated May 9, 2013, 16 pages. |
Office action dated Sep. 10, 2013 in counterpart Japanese Application No. 2011-516238, 4 pgs. |
Office action dated Sep. 24, 2014 in counterpart Japanese Application No. 2011-516238, 3 pgs. |
Examination Report dated Aug. 21, 2014 in counterpart Australian Application No. 2009352216, 3 pgs. |
Office action dated Mar. 20, 2012 in counterpart European Application No. 09827031.7, 11 pgs. |
Response to office action dated Sep. 18, 2012 in counterpart European Application No. 09827031.7, 25 pgs. |
International Preliminary Report on Patentability dated Feb. 28, 2012 in International Application No. PCT/US2009/041858, 6 pgs. |
Office Action dated Sep. 25, 2014 in related U.S. Appl. No. 12/768,633, 20 pgs. |
Promotional materials for DRD™ Diluter Corporation's Little Squirt™, NanoBlast-96™, and Differential NanoPipettor™/Diluter. |
Brochure—Iris Diagnostics Case Study: New Automated Urinalysis Workcell Review (2009). |
Promotional materials for DRD Diluter Corporation's Little Squirt (Jan. 7, 2008). |
Promotional materials for NanoBlast-96 (Feb. 28, 2006). |
Promotional materials for Differential NanoPipettorTM/Diluter, small volume sampling (Feb. 28, 2006). |
Promotional materials for Differential NanoPipettorTM/Diluter (Apr. 9, 2005). |
Canadian Office Action issued in related CA Appl. No. 2,761,630 dated Jun. 23, 2015, 5 pages. |
Japanese Office Action issued in related JP Appl. No. 2015-060503 dated Apr. 14, 2017, 5 pages. |
Advisory Action in U.S. Appl. No. 12/430,885, dated Jul. 19,2012, 3 pages. |
International Search Report and Written Opinion for PCT/US2011/021546, dated Oct. 10, 2011, 10 pages. |
Office Action in U.S. Appl. No. 12/430,885 dated Jan. 13, 2014, 7 pages. |
Office Action in U.S. Appl. No. 12/430,885 dated May 8, 2013, 18 pages. |
Office Action in U.S. Appl. No. 12/430,885, dated Apr. 12, 2012, 21 pages. |
Office Action in U.S. Appl. No. 12/430,885, dated Sep. 30, 2011, 23 pages. |
Restriction Requirement in U.S. Appl. No. 12/430,885, dated May 27, 2011, 10 pages. |
Number | Date | Country | |
---|---|---|---|
20150355078 A1 | Dec 2015 | US |
Number | Date | Country | |
---|---|---|---|
61047920 | Apr 2008 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12430885 | Apr 2009 | US |
Child | 14697331 | US |